Cargando…
Corrigendum to “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes”
Autores principales: | Qiu, Bo, Gong, Ming, He, Qi-Ting, Zhou, Pang-Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533790/ https://www.ncbi.nlm.nih.gov/pubmed/33029521 http://dx.doi.org/10.1155/2020/6942710 |
Ejemplares similares
-
Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes
por: Qiu, Bo, et al.
Publicado: (2016) -
Inhibition of interleukin-1beta-stimulated dedifferentiation of chondrocytes via controlled release of CrmA from hyaluronic acid-chitosan microspheres
por: Ma, Bei-lei, et al.
Publicado: (2015) -
Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta
por: Deng, Rong-Hui, et al.
Publicado: (2018) -
Corrigendum to: Hierarchically electrospraying a PLGA@chitosan sphere-in-sphere composite microsphere for multi-drug-controlled release
por: Liu, Zhu, et al.
Publicado: (2020) -
Corrigendum: Salvianolic acid B decreases interleukin-1β-induced colitis recurrence in mice
Publicado: (2023)